Welcome to Scientific Depth, i3's online information center that includes access to:
The Innovation Series
Articles, white papers and presentations that provide insight into the science and business of clinical research.
i3 InLine
Current and back issues of our monthly newsletter that presents unique i3 insights plus a summary of the top news impacting the pharma industry.
Engage
Current and back issues of our online newsletter offering timely insight into career matters, hiring practices, and workplace trends for clinical research professionals.
i3 Articles and White Papers
Published work and thought papers written by i3 specialists.
Case Studies
Reports on the results our clients have obtained by drawing on the specialized expertise of i3 scientists, researchers, and associated professionals, or from the use of our data products.
Scientific Presentations and Posters
Login or sign up now to gain access.
i3 InLine Spotlight Article:
Paradigm Shift Provides Pharma with Strategic Partnership Options for Outsourcing Health-economics Research
Although recent trends in pharmaceutical pricing and reimbursement have given rise to significant changes in drug development and marketing, the manner in which pharma companies outsource their health-economics research has remained unaltered. It now appears that change is coming. As internal research departments within pharma become increasingly overburdened, pharma companies are seeking a new, partnership-based business model with health-economics research firms that stands in stark contrast to the traditional, vendor-based arrangement that has characterized the business relationship for the past 25 years.
The movement toward a partnership-based relationship constitutes a real paradigm shift that wasn’t even possible until very recently, according to David Thompson, Ph.D., vice president, Global Health Economics, for i3 Innovus. “Historically, health-economics research firms were either too small, too specialized or too geographically limited for any one of them alone to be a viable sole-source partner for pharma,” he said. “But recent consolidation has given rise to a few large health-economics research firms, such as i3 Innovus, that have the depth and breadth to make the partnership-based business model a reality”.
Read the entire article
Sign up now for access to the entire brief!
October 1, 2008
Source: i3 InLine | 
